11 results
8-K
EX-99.1
ABOS
Acumen Pharmaceuticals Inc
17 Jul 23
Acumen Pharmaceuticals Presents Positive Topline Results from First-in-Human
6:06am
for INTERCEPT-AD patients as well as study recruitment techniques that were used to help Acumen recruit a diverse population for the trial.
The full results
10-K
2021 FY
ABOS
Acumen Pharmaceuticals Inc
28 Mar 22
Annual report
4:51pm
for identifying patients;
our ability to recruit clinical trial investigators with the appropriate competencies and experience;
the design of the trial … product launch. If the commercial launch of a product candidate for which we recruit a sales force and establish marketing capabilities is delayed or does
8-K
EX-99.1
ABOS
Acumen Pharmaceuticals Inc
15 Nov 21
Acumen Pharmaceuticals Reports Financial Results for Third Quarter 2021 and Business Highlights
8:12am
a clinical trial. We have cleared our sentinel safety review and are continuing to recruit patients in INTERCEPT-AD. We believe we have the resources
10-Q
mjog dfeed5a4y4sq88
16 Aug 21
Quarterly report
4:51pm
424B4
yhh6a 51s
2 Jul 21
Prospectus supplement with pricing info
4:09pm
S-1/A
zeckx4pr c3xwdmd5ps
24 Jun 21
IPO registration (amended)
8:17am
S-1
1bdjoosyud8aeoc7
9 Jun 21
IPO registration
5:02pm
DRS/A
lrvdkf9 wav85e2ndi
14 May 21
Draft registration statement (amended)
12:00am
DRS
ukd41t33 ignbv9
12 Apr 21
Draft registration statement
12:00am
- Prev
- 1
- Next